Masked T‑cell engagers: cancer immunotherapies for the future?
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called
